BMC Neurology | Full text | The clinical meaningfulness of ADAS-Cog changes in Alzheimer's disease p
In 6-month anti-dementia drug trials, a 4-point change in the Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) is held to be clinically important. We examined how this change compared with measures of clinical meaningfulness....